In the United States, 40 percent of all cancers are associated with modifiable risk factors.

In the US, the overall cancer death rate is declining steadily, thanks to rapid advances in treatments propelled by breakthroughs across the continuum of medical research.

Science-driven policies can expand access to care, strengthen public health programs, reduce cancer disparities, and help ensure that progress against cancer reaches every patient.